Susquehanna International Group
IBIO icon

Susquehanna International Group’s iBio IBIO Stock Holding History

Susquehanna International Group’s Portfolio IBIO Stock Details IBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-37,600
Closed -$51.5K – 12673
2023
Q4 		$51.5K Buy
37,600
+35,720
+1,900% +$156K ﹤0.01% 11703
2023
Q3 		$11.3K Sell
1,880
-45
-2% -$389 ﹤0.01% 11707
2023
Q2 		$23.5K Sell
1,925
-10,465
-84% -$197K ﹤0.01% 11597
2023
Q1 		$515K Buy
12,390
+6,410
+107% +$165K ﹤0.01% 8491
2022
Q4 		$52.6K Buy
5,980
+5,777
+2,846% +$195K ﹤0.01% 11365
2022
Q3 		$17K Sell
203
-159
-44% -$21.9K ﹤0.01% 12651
2022
Q2 		$47K Sell
362
-93
-20% -$14K ﹤0.01% 12011
2022
Q1 		$98K Buy
455
+140
+44% +$29.3K ﹤0.01% 11929
2021
Q4 		$87K Sell
315
-360
-53% -$137K ﹤0.01% 12229
2021
Q3 		$358K Sell
675
-682
-50% -$425K ﹤0.01% 10192
2021
Q2 		$1.02M Buy
1,357
+16
+1% +$11.7K ﹤0.01% 7694
2021
Q1 		$1.03M Buy
1,341
+1,001
+294% +$872K ﹤0.01% 7658
2020
Q4 		$179K Buy
340
+228
+204% +$186K ﹤0.01% 10126
2020
Q3 		$113K Buy
+112
New +$162K ﹤0.01% 9845

Other funds holding IBIO

AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return

Susquehanna International Group's IBIO Position: Q1 2026 in Review

Susquehanna International Group opened a new position in iBio (IBIO) in Q1 2026: 412,725 shares worth $784K. The stake represents ﹤0.01% of the portfolio and ranks #8523 among its holdings. This is a return to the name: Susquehanna International Group previously reported a position in IBIO as recently as Q3 2025.

Susquehanna International Group first reported a position in IBIO in Q4 2014 and has held it in 20 quarters since. The position peaked at $2.3M in Q1 2021. 52 funds tracked by Wall St. Rank hold IBIO as of Q1 2026.

  • Susquehanna International Group held 412,725 shares of iBio worth $784K as of Q1 2026.
  • iBio was a new Susquehanna International Group position in Q1 2026.
  • iBio made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #8523 holding.
  • Susquehanna International Group first reported a position in iBio in Q4 2014 and has held it in 20 quarters since.
  • Susquehanna International Group's iBio position peaked at $2.3M in Q1 2021.
  • 52 funds tracked by Wall St. Rank held iBio as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.